(1) Objectives: Evaluating the effect of intravenous lidocaine infusion during surgery on inflammatory factor levels based on glasgow prognostic score and neutrophil to lymphocyte ratio in patients candidate for mastectomy due to breast cancer
(2) Design: The present study is a double blind randomized clinical trial. All breast cancer patients with ASA: I, II referring to Imam Hosein hospital, Tehran, Iran, who were candidate for elective mastectomy were included. Totally 63 patients were allocated in to 2 groups of intervention (lidocaine) and control (normal saline) based on a random number table.
(3) Setting and conduct: General anesthesia was induced similarly for all patients, using midazolam 0.02 mg/kg, fentanyl 2-4 µg/kg, propofol 1-2 mg/kg and atracurium 0.5 mg/kg.
(4) Participants: Breast cancer patients candidate for elective mastectomy were included. History of renal or hepatic failure, cardiac dysrhythmia, hospital admission more than 5 days, infection in last 14 days, allergy to lidocaine, recent blood transfusion, blood transfusion during or after surgery, surgery duration more than 4 hours and drug abuse are exclusion criteria.
(5) Intervention: In intervention group, 1.5 mg/kg/hr intravenous lidocaine and in control group, the same volume of normal saline was infused intravenously.
(6) Main outcome measures: Glasgow prognostic score and neutrophil to lymphocyte ratio were calculated before surgery and 6, 24, 48 hours and 14 days after surgery.